In yesterday’s Wall Street session, GSK Plc ADR (NYSE:GSK) shares traded at $41.19, up 0.81% from the previous session.
GSK stock price is now -1.49% away from the 50-day moving average and 9.85% away from the 200-day moving average. The market capitalization of the company currently stands at $83.58B.
, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, GSK plc, 10% Owner bought 3,300,000 shares of the company’s stock on Dec 07 ’23. The stock was bought for $16,500,000 at an average price of $5.00. Upon completion of the transaction, the 10% Owner now directly owns 13,983,761 shares in the company, valued at $575.99 million. A total of 0.01% of the company’s stock is owned by insiders.
During the past 12 months, GSK Plc ADR has had a low of $33.33 and a high of $43.84. As of last week, the company has a debt-to-equity ratio of 1.35, a current ratio of 0.88, and a quick ratio of 0.62. According to the stock market information, the enterprise value for the company is $100.62B, which is based on a 13.77 price-to-earnings ratio, a 2.87 price-to-earnings-growth ratio, and a beta of 0.67. The fifty day moving average price for GSK is $41.86 and a two-hundred day moving average price translates $37.53 for the stock.
The latest earnings results from GSK Plc ADR (NYSE: GSK) was released for Dec, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $0.72, missing analysts’ expectations of $0.76 by -0.04. This compares to $0.82 EPS in the same period last year. The net profit margin was 16.25% and return on equity was 41.19% for GSK. The company reported revenue of $9.98 billion for the quarter, compared to $5.23 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 90.91 percent. For the current quarter, analysts expect GSK to generate $9.33B in revenue.
